| scholarly article | Q13442814 |
| P50 | author | Karen Steel | Q15109532 |
| Ruth Asehry-Padan | Q19749301 | ||
| Martin Hrabě de Angelis | Q28606776 | ||
| Nadav Ahituv | Q37374381 | ||
| Karen Avraham | Q56704862 | ||
| P2093 | author name string | Helmut Fuchs | |
| Alexandra Erven | |||
| Trevor Williams | |||
| Keren Guy | |||
| P2860 | cites work | Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation | Q24291566 |
| Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator | Q24291867 | ||
| The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules | Q24323939 | ||
| Identification of novel human WW domain-containing proteins by cloning of ligand targets | Q24336090 | ||
| The molecular basis of Boston-type craniosynostosis: the Pro148-->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences | Q24337025 | ||
| A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator | Q24534123 | ||
| The coactivator p15 (PC4) initiates transcriptional activation during TFIIA-TFIID-promoter complex formation | Q24598984 | ||
| Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control | Q28141560 | ||
| Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 | Q28211366 | ||
| Analysis of the DNA-binding and activation properties of the human transcription factor AP-2 | Q28271397 | ||
| Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties | Q28510687 | ||
| Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation | Q28511870 | ||
| Transcription factor AP-2 essential for cranial closure and craniofacial development | Q28513302 | ||
| AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice | Q28586197 | ||
| AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle | Q28587027 | ||
| Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye | Q28589877 | ||
| Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 | Q28594321 | ||
| The WW domain: linking cell signalling to the membrane cytoskeleton | Q30167655 | ||
| Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis | Q33515610 | ||
| Distal 6p deletion syndrome: a report of a case with anterior chamber eye anomaly and review of published reports | Q33681169 | ||
| The Sharpening of cochlear frequency selectivity in the normal and abnormal cochlea | Q33954764 | ||
| Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference | Q33957311 | ||
| Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull | Q34195193 | ||
| Transcriptional dysregulation in skeletal malformation syndromes | Q34561444 | ||
| lockjaw encodes a zebrafish tfap2a required for early neural crest development. | Q38349455 | ||
| Embryological and genetic aspects of middle ear development. | Q41718944 | ||
| Normal hearing in Splotch (Sp/+), the mouse homologue of Waardenburg syndrome type 1. | Q43435241 | ||
| Genome-wide, large-scale production of mutant mice by ENU mutagenesis. | Q43520565 | ||
| ENU mutagenesis reveals a highly mutable locus on mouse Chromosome 4 that affects ear morphogenesis | Q43937639 | ||
| A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma | Q45345481 | ||
| Tailchaser (Tlc): a new mouse mutation affecting hair bundle differentiation and hair cell survival. | Q50495456 | ||
| Hearing in chronic suppurative otitis media. | Q50558534 | ||
| Characterization of the activation domains of AP-2 family transcription factors. | Q52580795 | ||
| P433 | issue | 6 | |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 424-432 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Mammalian Genome | Q1348949 |
| P1476 | title | An ENU-induced mutation in AP-2alpha leads to middle ear and ocular defects in Doarad mice | |
| P478 | volume | 15 |
| Q36927177 | A new mouse mutant for the LDL receptor identified using ENU mutagenesis |
| Q37045093 | Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain |
| Q40982938 | Association of TFAP2A gene polymorphism with susceptibility to non-syndromic cleft lip with or without palate risk in south Indian population |
| Q42909559 | Characterization of ENU-mutant mice. Animal models for human diseases using morphological and molecular methods |
| Q49830752 | Genome-wide mapping of global-to-local genetic effects on human facial shape. |
| Q28592776 | Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme |
| Q50894494 | Neurobehavioral mutants identified in an ENU-mutagenesis project. |
| Q33837382 | Ocular manifestations of branchio-oculo-facial syndrome: report of a novel mutation and review of the literature. |
| Q34876963 | Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators |
| Q48081611 | Spectrum of ENU-induced mutations in phenotype-driven and gene-driven screens in the mouse. |
| Q24655671 | TFAP2A mutations result in branchio-oculo-facial syndrome |
| Q46839098 | The Tennessee Mouse Genome Consortium: identification of ocular mutants |
Search more.